Enterococcus faecalis plays a significant role in hospital-acquired infections (HAIs), and combination of penicillin with aminoglycoside is important in therapy of invasive HAIs. Penicillin resistance in this organism is due to modification of the drug target, penicillin-binding protein (PBP5), its overproduction and expression of β-lactamase. Although rare, this phenotype is o en associated with multi-resistant high-risk enterococcal clonal complexes (HiRECCs), such as CC2 and CC9 which may promote its spread in the near future. 
Enterococci are a part of natural intestinal ora of both human and animals. ese Gram-positive bacteria are typically harmless commensals, but in particular conditions they can also cause serious infections. So far, several Enterococcus species have been identified (Hardie and Whiley, 1997), of which two, Enterococcus faecalis and Enterococcus faecium have gained clinical importance. Enterococci have emerged as a serious nosocomial pathogens in the 1990s (Edwards, 2000) , and their impact is increasing due to growing numbers of patients at-risk (Sydnor and Perl, 2011) . Enterococci were reported as the third most common cause of hospital-associated infections in the United States (Hidron et al., 2008) . While the majority (around 80%) of enterococcal infections in humans is caused by E. faecalis (Jett et al., 1994 ; European Centre for Disease Prevention and Control, 2010) , the prevalence of E. faecium is currently on the rise (Top et al., 2007; Lester et al., 2008; Hidron et al., 2008) . e most serious forms of infection caused by E. faecalis are endocarditis and bloodstream infections; other diseases include urinary tract infections (UTIs) and post-surgery wound infections (Jett et al., 1994) ; central nervous system and neonatal infections occur with low frequency (Murray, 1998) .
Enterococci possess several traits that facilitate dissemination and survival in the hospital settings, and make theirs infections difficult to treat; they are able to grow in the range of 10-45°C, at pH 9.5, in presence of 6.5% NaCl and to survive at 60° for 30 min (Sherman, 1937) . Enterococci show an intrinsic lack of susceptibility to various antibiotics, including cephalosporins, monobactams, sulphonamides, low concentrations of aminoglycosides, as well as, in the case of E. faecalis, streptogramins and lincosamides. Increasing anti biotic resistance is associated with the capability of these bacteria to acquire and to transfer mobile genetic elements encoding resistance genes (Marothi et al., 2005; Palmer et al., 2010) . e resistance to antibiotics can be also developed due to spontaneous mutations. Hospitalassociated strains of E. faecalis o en present acquired resistance to antibiotics of several classes such as tetracyclines, quinolones and high-level aminoglycoside resistance (HLAR), while vancomycin-resistant enterococci (VRE) of this species remain rare (Marothi et al., 2005; Hidron et al., 2008) . e HLAR phenotype in E. faecalis is of particular concern as the combination of aminoglycoside with penicillin (ampicillin or penicillin G) represents a therapy of choice for enterococcal invasive infections (Arias and Murray, 2008) . Combination of these two drugs has a synergistic bactericidal e ect on enterococci (Moellering and Weinberg, 1971) . Normally, the enterococcal cell-wall is poorly permeable for aminoglycosides but these drugs can penetrate to the intracellular target (ribosome) in the presence of the cell-wall synthesis inhibitors as like β-lactams. In Europe, percentage of HLAR among E. faecalis reach relatively high values -from 30% to 50% (European Centre for Disease Prevention and Control, 2010) . 154
In recent years, we witness an emergence of penicillin-resistant E. faecalis isolates in hospital environment.
ree mechanisms for penicillin resistance in E. faecalis have been reported, and include (i) production of β-lactamase which inactivates the drug, (ii) overproduction of the drug target, penicillin-binding proteins (PBPs) and (iii) their decreased affinity for β-lactams.
Determination and interpretation criteria of penicillin susceptibility in E. faecalis
According to the guidelines of Clinical and Laboratory Standard Institute (CLSI) determination of E. faecalis susceptibility to penicillin and ampicillin can be carried out with the use of either disc di usion method or by establishing the minimal inhibitory concentration (MIC) values by an agar or broth dilution methods (Clinical and Laboratory Standard Institute, 2011 In addition, the EUCAST provides so-called epidemiological cut-o values (ECOFFs), which separate the wild-type (WT) strains from the strains that exhibit acquired and mutational resistance mechanisms to the drug in question. In the case of E. faecalis, the ECOFF value for penicillin is 16 µg/ml, and for ampicillin is 4 µg/ml, i.e. the WT strains show MICs lower than or equal to this values. According to MIC distributions determined by the EUCAST, for most of the E. faecalis strains MIC of penicillin ranges between 2 and 4 µg/ml and MIC of ampicillin ranges between 1 and 2 µg/ml (www.eucast.org/mic_distributions/; 16 th November 2011, date last accessed).
Resistance due to the target modification
Penicillin-binding proteins (PBPs) are produced by almost all bacteria. ese membrane proteins are involved in the final stages of peptidoglycan synthesis. Binding β-lactam antibiotic to PBPs inhibits enzymatic activity of protein and leads to cell growth inhibition or cell death (Lleó et al., 1987) . However, certain PBPs show lower affinity to penicillin and because of that, they are responsible for reduced susceptibility to penicillin in a number of Gram-negative and Gram-positive bacteria, including enterococci (Fontana et al., 1983; Canepari et al., 1986; 1987) . Low-affinity PBPs replace other PBPs, inhibited by drugs and take over their transpeptidase function (Fontana et al., 1983; 1985) .
E. faecalis produces five PBPs, including four highmolecular weight PBPs and one low-molecular weight PBP (Williamson et al., 1983 , Duez et al., 2001 Ono et al., 2005) . One of these PBPs, designed PBP5, and sometimes named PBP4, is a low-affinity PBP, and its changes and/or overproduction can be related to penicillin resistance. e E. faecalis PBP5 encoded by the genome of V583 strain (Paulsen et al., 2003) is a high-molecular weight protein of about 75 kDa (680aa) and is organized in three distinct domains. e N-terminal hydrophobic domain, about 30aa long, is responsible for PBP5 anchoring to the cell membrane (Ghuysen et al., 1996; Signoretto and Canepari, 2000) . e penicillin-binding domain, with typical penicillinbinding motifs, 424 SXXK 427 , 482 SDN 484 and 619 KTG 621 , is localized at the C-terminus of the protein (Zapun et al., 2008) . ese two parts are connected by a central non-penicillin-binding domain of presumable transglycosylase activity proposed by analogy with high-molecular-weight Escherichia coli PBPs (Ghuysen et al., 1996; Signoretto and Canepari, 2000) . Non-penicillin-binding domain seems to be essential for the proper folding, stability and the biochemical activity of the penicillin-binding domain, like in E. hirae (Mollerach et al., 1996) . is specific structure classifies enterococcal PBP5 in the class B multimodular PBPs (Ghuysen et al., 1996) .
PBP5 of E. faecalis is closely related to the other enterococcal low-affinity PBPs described previously (Zorzi et al., 1996) . Importance of alterations in PBP5 caused by point mutations for β-lactam resistance is well-described in E. faecium (Ligozzi et al., 1996; Zorzi Rybkine et al., 1998) . Amino acid substitutions in the region between motifs SDN and KTG of the penicillin-binding domain are involved in the resistance to penicillin and ampicillin by decreasing affinity to these drugs (Ligozzi et al., 1993; Fontana et al., 1996; Ligozzi et al., 1996) . Similarly, mutations within the PBP5 penicillin-binding domain in E. faecalis result in the decrease of affinity and susceptibility to β-lactam antibiotics. Such isolates were first detected in Japan in 1998-2002 (Ono et al. 2005) . Four clinical isolates with ampicillin MIC values 8-16 µg/ml harbored amino acid alterations of PBP5 at the amino acid positions 520 and 605 (P520S and Y605H), i.e. located in the region between the SDN and KTG motifs of the penicillinbinding domain (Ono et al., 2005) . ese isolates also showed elevated MICs for imipenem; susceptibility to penicillin was not reported in this study. Mutations in the same amino acid positions were detected in UTI clinical isolates with reduced faropenem susceptibility, also found in Japan (Hiraga et al., 2008) . Di erent kind of modifications was observed in the laboratory mutant strain 56R with high penicillin and ampicillin MIC values equal 128 µg/ml and 64 µg/ml, respectively (Signoretto et al., 1994; Signoretto and Canepari, 2000) .
Comparison of the deduced amino acid sequence of PBP5 from 56R with its counterpart in the JH2-2 susceptible strain revealed that the resistant strain harbors a small frameshi mutation in the non-penicillinbinding domain (the peptide 272 AAAQLIGYTG 281 is replaced by 272 ACAINRVYG 280 , resulting in a protein shorter by a single amino acid residue), as well as the T/I mutation, immediately adjacent to the K residue in the SXXK motif (Duez et al., 2001) . As the corresponding sequence of the parental susceptible strain 56 was not available, it was not possible to draw reliable conclusion about these changes (Duez et al., 2001 ). e role of PBP5 for decreased susceptibility to β-lactams in E. faecalis is further supported by the fact that inactivation of the pbp5 gene in the 56 strain by Tn916 mutagenesis resulted in 8-fold decrease in the penicillin MIC value of the PBP5-defficient strain (Signoretto and Canepari, 2000) .
Resistance mediated by the PBP overproduction
e overproduction of the drug target appears to be another important mechanism of penicillin resistance in clinical isolates and laboratory mutants of E. faecalis, and was also observed in other enterococcal species such as E. faecium, Enterococcus avium and Enterococcus durans (Fontana et al., 1994; al-Obeid et al., 1990) . e exposure of susceptible E. faecalis strains to penicillin led to selection of penicillin-resistant mutants with hyperproduction of PBP5 and this type of resistance was developing both through serial passages on plates containing increasing concentrations of penicillin (al-Obeid et al., 1990; Hodges et al., 1992; Duez et al., 2001 ) and under continuous penicillin exposure (Hodges et al., 1992) . A detailed analysis of the JH2-2r strain with penicillin MIC value of 75 µg/ml, overproducing PBP5, and its parental susceptible strain JH2-2 confirmed that both strains harbor identical pbp5 gene (Duez et al., 2001) . Apparently increased amount of PBP5 were also observed in E. faecalis from hospital settings in Spain (Cercenado et al., 1996) . ese two clinical isolates showed MIC values of 64 µg/ml and 32-64 µg/ml for penicillin and ampicillin, respectively, and were isolated independently from two patients with UTI, treated with ampicillin (Cercenado et al., 1996) . e molecular basis of PBP5 overproduction in E. faecalis has not yet been clarified. In E. hirae, synthesis of PBP5 is under the control of the psr gene (PBP5 synthesis repressor), located upstream pbp5, and alteration of psr by a point mutation or deletion results in the elevated expression of PBP5 (Ligozzi et al., 1993) . In E. faecalis, however, no such gene is present in the proximity of to pbp5, and psr-like gene located elsewhere in the genome showed exactly the same sequence in the penicillin-resistant mutant JH2-2r, described above, in comparison to the JH2-2 parental strain. Moreover, the pbp5 promoter region in both strains was identical (Duez et al., 2001) . erefore, the pathway leading to PBP5 overexpression in E. faecalis remains to be elucidated.
Resistance due to β-lactamase acquisition
β-Lactamase production is another mechanism of resistance penicillin, so far restricted almost exclusively to E. faecalis.
e first β-lactamase producing (Bla+) enterococcal isolate, HH22, was detected in Houston, Texas, in 1981 (Murray and MederskiSamaraj, 1983) . MIC values for penicillin and ampicillin of HH22 were above 1000 µg/ml, when the high inoculum of 10 7 CFU/ml was used (Murray et al., 1986a) . Since then, Bla+ enterococci became more prevalent and were isolated from severe infections and nosocomial outbreaks Patterson et al., 1988a; Rhinehart et al., 1990; Wells et al., 1992; Mazzulli et al., 1992) . β-Lactamase from E. faecalis is a typical penicillinase, able to hydrolyze penicillin, ampicillin and ureidopenicillins (e.g. piperacillin), and sensitive to inhibitors such as clavulanic acid (Murray et al., 1986b) .
Most likely, enterococci acquired the β-Lactamase gene from staphylococci (Murray et al., 1986b) . e E. faecalis HH22 carries the blaZ gene, whose sequence 156 is identical to the staphylococcal blaZ genes from the pC1 and pS1 plasmids (Zscheck and Murray, 1991) , and from staphylococcal Tn552 transposon . In contrast to the inducible production of large amounts of β-Lactamase by Staphylococcus aureus, E. faecalis produces the enzyme constitutively on relatively low level (Murray et al., 1986a; Okamoto et al., 1996) . Particular enterococcal clones may di er by the presence of the regulatory genes blaR1 (encoding antirepresor) and blaI (encoding repressor) from the bla gene cluster of S. aureus. For example, the HH22 strain possesses only a part of blaR1 and lacks blaI (Zscheck and Murray, 1993) . Even if these genes are present, the β-lactamase is still produced constitutively. It is possible that blaR1 and blaI contain mutations which make them non-functional or that these regulatory proteins are not active in the enterococcal cell (Zscheck and Murray, 1991; Okamoto et al., 1996; Tomayko et al., 1996) .
In E. faecalis, blaZ genes reside either on conjugative plasmids (Murray et al., 1986a , b, Patterson et al., 1988b Markowitz et al., 1991) , or on bacterial chromosome Chow et al., 1993) . e blaZ gene in the first described Bla+ isolate HH22 was shown to be present on the ~70 kb pheromone-responsive conjugative plasmid pBEM10 that was transferred with a high frequency of 10 -2 (Murray et al., 1988) . Efficient conjugative transfer of pheromone-responsive plasmids, specific for enterococci, is due to the unique mechanism of response to so-called sex pheromones, secreted by recipient cells lacking a particular type of plasmid. Stimulated donor cells respond by production of proteins necessary for cell-to-cell contact and subsequent plasmid transmission (Dunny, 1990; Palmer et al., 2010) . e pBEM10 plasmid responds to the cAD1 pheromone and uses the same pheromone system as pAD1 (Murray et al., 1988) with which it shares extensive homology (Galli and Wirth, 1991) . e chromosome-located blaZ gene, detected in isolates from Boston, was transferable at low frequency (below 10 -8 ), together with determinants of resistance to a number of other antimicrobials such as erythromycin, gentamicin, mercuric chloride, streptomycin, and tetracycline . Later on it was shown that blaZ is associated with a composite ~60 kb transposon Tn5385 which structure was a subject of several studies. Tn5385 comprises sequences of transposons, such as (1) Tn5381 that carries the tetM gene (Rice et al., 1992) , (2) Tn5384, that itself contains Tn4001 with the aacAaphD gene (responsible for gentamicin resistance) and a derivative of Tn917 with the ermB gene (erythromycin resistance determinant) (Rice et al., 1995; Bonafede et al., 1997) and (3) possesses two replication genes of pAMβ1, a broadhost range plasmid originally described in E. faecalis, a gene homologous to the putative relaxase gene from small, mobilizable staphylococcal plasmid pS194 and three types if insertions sequences (IS256, IS257, and IS1216), indicating a complex series of co-integration events (Rice and Carias, 1998; Bonafede et al., 1997) .
Almost all Bla+ E. faecalis isolates identified so far belong to two clonal complexes, BVE (Bla + Van r endocarditis) and ACB (Argentina-Connecticut-Bla + ), suggesting a limited number of transfer events of staphylococcal blaZ gene to E. faecalis (Nallapareddy et al., 2005) . e BVE clonal complex includes the first Bla+ isolate HH22 (Nallapareddy et al., 2005) and the members of BVE were found spreading in five states (Delaware, Texas, Pennsylvania, Florida, and Virginia) of North America , including a sevenyear outbreak in a Virginia hospital where they were named the mid-Atlantic clone (Seetulsingh et al., 1996) . BVE was also responsible for bloodstream infections in a North Carolina hospital (Murdoch et al., 2002) . Representatives of this clone are also o en associated with glycopeptide resistance and possess a pathogenicity island (Nallapareddy et al., 2005) , thus demonstrating a high pathogenic potential and adaptation to the hospital environment. e ACB clonal complex occurred in hospital outbreaks in Connecticut and Argentina . Application of multilocus sequence analysis (MLST) to BVE and ACB isolates clustered them into hospital-associated clonal complexes, CC2 and CC9, respectively (RuizGarbajosa et al., 2006 ). e described above isolates from Boston carrying the Tn5385 transposon also belonged to CC9 (McBride et al. 2007) . Both CC2 and CC9 are considered high-risk enterococcal clonal complexes, or HiRECCs (Leavis et al., 2006) . Only a single isolate Bla+ from Beirut, Lebanon, did not belong to any of these two HiRECCs (Nallapareddy et al., 2005; Ruiz-Garbajosa et al., 2006) . Diversity of blaZ sequence and variable presence of regulatory genes blaR1 and blaI within the mid-Atlantic/BVE clone suggests that the bla gene cluster has originated from more than one source or the gene cluster has diverged significantly a er acquisition .
Current epidemiology of penicillin resistance in E. faecalis e resistance to penicillin in clinical isolates of E. faecalis remains a relatively rare phenomenon. A large TEST study collecting isolates in 266 centers in North and Latin America, Asia and Europe in 2004-2006 reported 100% susceptibility to penicillin and ampicillin among 2701 isolates of E. faecalis (Reinert et al., 2007) . Analysis of the Surveillance Network databases, collecting susceptibility data of predominant ICU pathogens during 2000-2002 from 650 hospitals in Europe (France, Germany and Italy), Canada, and the US revealed ampicillin resistance ranging from 0.2% (France) to 4.7% (Italy) among 7865 isolates of E. faecalis (Jones et al., 2004) . Some of national studies recently report much higher ratios of penicillin resistance (Table II) . In general, little is known about clonal relationships of current penicillin-resistant E. faecalis. Recently, twenty E. faecalis isolates from bloodstream infections from seven hospitals in Denmark collected in 2007 displaying reduced susceptibility to penicillin (MIC > 16 µg/ml by the Etest method and 4-8 µg/ml by the broth microdillution method) and full ampicillin susceptibility were reported. Most of these isolates (17) belonged to the same sequence type ST6 of CC2. e mechanism underlying this phenotype was not studied (Guardabassi et al., 2010) . Pulsed-field gel electrophoresis (PFGE) analysis of 90 penicillin-resistant but ampicillin-susceptible isolates from Greece revealed that the majority (52) of them belonged to a single genotype while the remaining 38 isolates were grouped in five genotypes (Metzidie et al., 2006) . None of these isolates produced β-lactamase (Table II) .
Conclusions and perspectives
Penicillin and ampicillin play an important role in the treatment of serious infections caused by E. faecalis and the development of resistance to these drugs implies serious clinical problems, especially as it excludes a synergistic bactericidal e ect of β-lactams in combination with aminoglycosides. e first cases of ampicillin-resistant E. faecium (AREfm) were identified in the early 1980s. AREfm isolates have emerged as a causative agent of nosocomial infections and outbreaks (Coudron et al., 1984) . Generally, ampicillin resistance has become a typical trait for hospitalassociated strains of E. faecium, in particular of CC17, a HiRECC found in hospitals all over the world. One of the first steps of hospital-adaptation of CC17 was acquisition of ampicillin resistance (Leavis et al., 2006; Galloway-Peña et al., 2009 ). Although still rare, penicillin resistance can be also acquired by E. faecalis via various mechanisms and is o en associated with HiRECCs circulating in hospitals. Moreover, the determinants of the resistance, such as β-lactamase genes, have a potential to be transferred to susceptible strains due to their localization on pheromone-responsive plasmids and within conjugative transposons. ese elements contribute to the resistance spread among di erent species of bacteria, such as acquisition of β-lactamase gene from staphylococci by E. faecalis (Murray et al., 1986b) and subsequent transmission of the trait to E. faecium (Coudron et al., 1992) . Also chromosomal determinant, pbp5, may disseminate in the population of E. faecalis due to frequent recombination in this species (RuizGarbajosa et al., 2006) . It is necessary to observe phenomenon of penicillin-resistance among E. faecalis.
